Preclinical Animal Models to Power Up Psychiatric Drug Development
Ace Therapeutics, a preclinical contract research organization (CRO) actively engaged in mental illness research, has announced the launch of its model development services, which aim to revolutionize psychiatric drug research and development. Psychiatric drug development is a crucial aspect of mental health treatment, as it involves the development of medications that can effectively treat…
Advance Stroke Drug Development through ADME/DMPK Study
Ace Therapeutics, one of the leading preclinical CRO companies for stroke, is excited to announce the expansion of its services with the addition of ADME/DMPK services to support stroke drug development. Drug metabolism and pharmacokinetics (DMPK) play a crucial role in the drug development process for stroke. DMPK studies involve the evaluation of how…